Lawmakers push health insurers, PBMs to sell pharmacy businesses

PBM and telehealth measures falter in Congress' year-end rush

How Pharmacy Benefit Managers Are Harming Patients—and What Policymakers Can Do About It

The Costly Failures Of Medicine’s Middlemen

PBM Math: Big Chains Are Paid $23.55 To Fill a Blood Pressure Rx. Small Drugstores? $1.51

Employers Haven’t a Clue How Their Drug Benefits Are Managed

Senators Call on FTC to Investigate PBM Co-Manufacturing Tactic

The ERISA Industry Committee Calls on Congress to Close Loophole and Deem PBMs as a “Fiduciary” under ERISA

Federal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices

Pharmacy Benefit Managers Are Killing Indie Pharmacies and Limiting Patient Choice

PBM executives decline to revise controversial testimony to House committee

It’s Not Just Big Pharma: Meet the Middlemen Blocking Access to Medication

PBM executives threatened with fines and jail time for alleged perjury in House hearing

Higher Drug Costs, Less Choice: How PBMs Affect Everyday Americans’ Healthcare

States Keep Legal Pressure on PBMs Ahead of Potential FTC Suit

Drug middlemen say Pharma sets prices. Then why do middlemen have hundreds for the same drug?

NCPA Leads Retail Pharmacy in a Class Action Suit Against Change Healthcare, UnitedHealth Group, and Optum for Data Breach and Losses

Do pharmacy benefit managers play a role in pharmacy closures?

Feds poised to sue pharmacy gatekeepers over high drug costs

Pharmacy benefit managers profit at expense of patients and small pharmacies, FTC says